Remove 2020 Remove Adverse Reactions Remove Labelling
article thumbnail

STAT+: Experts critique flawed system for monitoring drugs’ side effects in wake of asthma drug report

STAT

and globally, for monitoring adverse reactions after a drug is on the market — one that will require extensive changes to address. Experts say that the Singulair incident highlights a flawed system, both in the U.S.

article thumbnail

FDA Accepts Pfizer’s sNDA for BRAFTOVI + MEKTOVI

LifeProNow

These sNDAs are supported by results from the PHAROS trial ( NCT03915951 ), an open-label, multicenter, non-randomized, Phase 2 study (n=98) to determine the safety, tolerability, and efficacy of BRAFTOVI given in combination with MEKTOVI in patients with BRAF V600E-mutant metastatic NSCLC. of patients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharmacovigilance deep dive: risk minimisation measures

European Pharmaceutical Review

This can be achieved by reducing the burden of adverse reactions or by optimising benefits through patient selection (eg, contraindications, recommendations of use, warnings, concomitant medicine[s], or certain test parameters) and treatment management (eg, specific dosing regimen, relevant testing, patient follow-up).

article thumbnail

OPDP Says TV Ad is Out of Bounds with Fourth Untitled Letter of 2024

FDA Law Blog: Biosimilars

The approved labeling for UBRELVY includes a warning and precaution regarding hypersensitivity reactions, with the most common adverse reactions being nausea and somnolence. on March 10, 2020.

article thumbnail

Nextstellis®: A new drug update 

Birth Control Pharmacist

Adverse Reactions. The most common adverse reactions (>2%) were bleeding irregularities, dysmenorrhea, headaches, mood disturbance, increase weight, acne, decrease libido and breast symptoms. Available at: www.accessdata.fda.gov/drugsatfda_docs/label/2021/214154s000lbl.pdf. Published April 7, 2020.

article thumbnail

The Fundamental Gut Health Protocol

The Thyroid Pharmacist

While most systemic enzyme product labels will state to take six capsules daily, this is typically considered to be more of a maintenance dose. However, those with small intestinal bacterial overgrowth (SIBO), may have an adverse reaction and should steer clear of fermented foods until they’re further along in their healing journey.

article thumbnail

Selenium: The Nutrient That Can Reduce Thyroid Antibodies by 40%

The Thyroid Pharmacist

Since one of the supplements I recommend, Pure Encapsulations Selenium , can contain up to 320 mcg per capsule (specifications state that the product can contain up to 160 percent of the label claim), it is not recommended for children. Published 2020 Jun 30. doi:10.1155/2020/9210572. Int J Endocrinol. 2020;2020:9210572.

Dosage 59